Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 7 |
GO:0043226 | organelle | 2 | 8 |
GO:0043227 | membrane-bounded organelle | 3 | 7 |
GO:0043229 | intracellular organelle | 3 | 8 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A0A3Q8IRD2
Term | Name | Level | Count |
---|---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | 8 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006355 | regulation of DNA-templated transcription | 6 | 1 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 1 |
GO:0006364 | rRNA processing | 8 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009890 | negative regulation of biosynthetic process | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016072 | rRNA metabolic process | 7 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045892 | negative regulation of DNA-templated transcription | 7 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1902679 | negative regulation of RNA biosynthetic process | 7 | 1 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 1 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 8 | 1 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0003677 | DNA binding | 4 | 8 |
GO:0005488 | binding | 1 | 9 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 98 | 102 | PF00656 | 0.696 |
CLV_NRD_NRD_1 | 127 | 129 | PF00675 | 0.672 |
CLV_NRD_NRD_1 | 208 | 210 | PF00675 | 0.787 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.787 |
CLV_PCSK_KEX2_1 | 286 | 288 | PF00082 | 0.565 |
CLV_PCSK_PC1ET2_1 | 129 | 131 | PF00082 | 0.547 |
CLV_PCSK_PC1ET2_1 | 286 | 288 | PF00082 | 0.581 |
CLV_PCSK_SKI1_1 | 159 | 163 | PF00082 | 0.719 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.776 |
CLV_PCSK_SKI1_1 | 283 | 287 | PF00082 | 0.654 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.643 |
DEG_COP1_1 | 239 | 247 | PF00400 | 0.691 |
DEG_SIAH_1 | 149 | 157 | PF03145 | 0.583 |
DOC_MAPK_gen_1 | 128 | 137 | PF00069 | 0.708 |
DOC_MAPK_gen_1 | 226 | 233 | PF00069 | 0.637 |
DOC_MAPK_HePTP_8 | 125 | 137 | PF00069 | 0.558 |
DOC_MAPK_MEF2A_6 | 128 | 137 | PF00069 | 0.782 |
DOC_PP2B_LxvP_1 | 231 | 234 | PF13499 | 0.619 |
DOC_USP7_MATH_1 | 113 | 117 | PF00917 | 0.732 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.728 |
DOC_USP7_UBL2_3 | 191 | 195 | PF12436 | 0.721 |
DOC_USP7_UBL2_3 | 274 | 278 | PF12436 | 0.620 |
DOC_USP7_UBL2_3 | 286 | 290 | PF12436 | 0.485 |
DOC_USP7_UBL2_3 | 56 | 60 | PF12436 | 0.577 |
DOC_WW_Pin1_4 | 167 | 172 | PF00397 | 0.729 |
DOC_WW_Pin1_4 | 183 | 188 | PF00397 | 0.741 |
DOC_WW_Pin1_4 | 197 | 202 | PF00397 | 0.712 |
DOC_WW_Pin1_4 | 226 | 231 | PF00397 | 0.707 |
LIG_14-3-3_CanoR_1 | 235 | 239 | PF00244 | 0.670 |
LIG_14-3-3_CanoR_1 | 287 | 293 | PF00244 | 0.576 |
LIG_Actin_WH2_2 | 251 | 266 | PF00022 | 0.523 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.710 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.707 |
LIG_FHA_1 | 244 | 250 | PF00498 | 0.624 |
LIG_FHA_1 | 271 | 277 | PF00498 | 0.642 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.347 |
LIG_FHA_2 | 249 | 255 | PF00498 | 0.637 |
LIG_FHA_2 | 29 | 35 | PF00498 | 0.472 |
LIG_FHA_2 | 296 | 302 | PF00498 | 0.523 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.380 |
LIG_LIR_Gen_1 | 28 | 38 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 28 | 33 | PF02991 | 0.373 |
LIG_MYND_1 | 230 | 234 | PF01753 | 0.699 |
LIG_PDZ_Class_1 | 311 | 316 | PF00595 | 0.509 |
LIG_PTAP_UEV_1 | 149 | 154 | PF05743 | 0.591 |
LIG_SH2_STAP1 | 284 | 288 | PF00017 | 0.516 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.541 |
LIG_SH3_1 | 147 | 153 | PF00018 | 0.595 |
LIG_SH3_3 | 10 | 16 | PF00018 | 0.426 |
LIG_SH3_3 | 147 | 153 | PF00018 | 0.788 |
LIG_SH3_3 | 218 | 224 | PF00018 | 0.819 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.716 |
LIG_SH3_4 | 15 | 22 | PF00018 | 0.501 |
LIG_SH3_4 | 191 | 198 | PF00018 | 0.726 |
LIG_TRAF2_1 | 251 | 254 | PF00917 | 0.592 |
LIG_TRAF2_1 | 52 | 55 | PF00917 | 0.507 |
LIG_UBA3_1 | 38 | 45 | PF00899 | 0.315 |
LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.422 |
LIG_WRC_WIRS_1 | 244 | 249 | PF05994 | 0.574 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.565 |
MOD_CK1_1 | 236 | 242 | PF00069 | 0.567 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.593 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.380 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.686 |
MOD_CK2_1 | 137 | 143 | PF00069 | 0.701 |
MOD_CK2_1 | 248 | 254 | PF00069 | 0.577 |
MOD_CK2_1 | 295 | 301 | PF00069 | 0.514 |
MOD_CK2_1 | 49 | 55 | PF00069 | 0.434 |
MOD_Cter_Amidation | 224 | 227 | PF01082 | 0.671 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.767 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.710 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.699 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.708 |
MOD_GlcNHglycan | 265 | 268 | PF01048 | 0.582 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.640 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.659 |
MOD_GSK3_1 | 197 | 204 | PF00069 | 0.740 |
MOD_GSK3_1 | 263 | 270 | PF00069 | 0.591 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.380 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.690 |
MOD_LATS_1 | 158 | 164 | PF00433 | 0.582 |
MOD_N-GLC_1 | 311 | 316 | PF02516 | 0.556 |
MOD_N-GLC_1 | 66 | 71 | PF02516 | 0.591 |
MOD_N-GLC_2 | 7 | 9 | PF02516 | 0.492 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.622 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.610 |
MOD_NEK2_2 | 267 | 272 | PF00069 | 0.552 |
MOD_OFUCOSY | 25 | 32 | PF10250 | 0.525 |
MOD_PIKK_1 | 103 | 109 | PF00454 | 0.648 |
MOD_PKA_1 | 195 | 201 | PF00069 | 0.832 |
MOD_PKA_2 | 234 | 240 | PF00069 | 0.671 |
MOD_PKA_2 | 263 | 269 | PF00069 | 0.547 |
MOD_Plk_2-3 | 97 | 103 | PF00069 | 0.785 |
MOD_Plk_4 | 243 | 249 | PF00069 | 0.579 |
MOD_ProDKin_1 | 167 | 173 | PF00069 | 0.729 |
MOD_ProDKin_1 | 183 | 189 | PF00069 | 0.741 |
MOD_ProDKin_1 | 197 | 203 | PF00069 | 0.713 |
MOD_ProDKin_1 | 226 | 232 | PF00069 | 0.706 |
MOD_SUMO_for_1 | 213 | 216 | PF00179 | 0.720 |
MOD_SUMO_rev_2 | 212 | 222 | PF00179 | 0.722 |
TRG_DiLeu_BaEn_3 | 253 | 259 | PF01217 | 0.625 |
TRG_DiLeu_BaLyEn_6 | 227 | 232 | PF01217 | 0.675 |
TRG_ER_diArg_1 | 127 | 130 | PF00400 | 0.573 |
TRG_ER_diArg_1 | 208 | 210 | PF00400 | 0.780 |
TRG_NLS_MonoCore_2 | 13 | 18 | PF00514 | 0.447 |
TRG_NLS_MonoExtN_4 | 156 | 163 | PF00514 | 0.703 |
TRG_Pf-PMV_PEXEL_1 | 278 | 282 | PF00026 | 0.557 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PGN4 | Leptomonas seymouri | 53% | 100% |
A4HHF0 | Leishmania braziliensis | 70% | 99% |
A4HHF1 | Leishmania braziliensis | 66% | 99% |
A4I4K0 | Leishmania infantum | 99% | 100% |
C9ZL83 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9ADZ9 | Leishmania major | 90% | 100% |
E9ALT2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |